• Home
  • Products
    • Harm Reduction
      • Fentanyl (FYL) Testing
      • Xylazine (XYL) Testing
      • Medetomidine (MED) Testing
      • Nitazene (NTZ) Testing
      • Benzodiazepine (BZO) Testing
      • Microscoops
      Drug Screening
      • Workflow Solutions
      • Urine
      • Saliva
      • ESA Tests
      Alcohol
      • Saliva
      • Urine
      Spiked Drink Detection
      • Spiked Drink Testing
      Infectious Diseases
      • COVID-19
      • RSV
      • H. pylori
      Urinalysis
      • Urinary Tract Infection
      • Analyzers
      • Reagent Strips
      • Controls (UA)
      Women's Health
      • Pregnancy
      Cancer Screening
      • Colon Cancer Screening (FIT)
      Accessories
      • Urine Specimen Cups
      • Specimen Collection Accessories
      • Gloves
      • Misc
  • Harm Reduction
  • Services
  • About Us
  • Blog
  • Contact Us
  • Log In
    • Log in

    • New Customer? Request an account.
  • Order Form
close×
 
  • HOME
  • Cancer Screening

Cancer Screening

Rapid Response Diagnostics cancer screening products FIT test buffer, cassette, and kit box

The Rapid Response™ Fecal Immunochemical Test (FIT) is an immunochromatographic assay intended for the determination of human hemoglobin in feces by professional laboratories or physician’s offices. It is useful to determine gastrointestinal bleeding found in a number of gastrointestinal disorders such as colorectal carcinoma, colon polyps, diverticulitis and ulcerative colitis.

Categories

  • Harm Reduction
    • Fentanyl (FYL) Testing
    • Xylazine (XYL) Testing
    • Medetomidine (MED) Testing
    • Nitazene (NTZ) Testing
    • Benzodiazepine (BZO) Testing
    • Microscoops
    • See More
  • Drug Screening
    • Workflow Solutions
    • Urine
    • Saliva
    • ESA Tests
    • See More
  • Alcohol
    • Saliva
    • Urine
    • See More
  • Spiked Drink Detection
    • Spiked Drink Testing
    • See More
  • Infectious Diseases
    • COVID-19
    • RSV
    • H. pylori
    • See More
  • Urinalysis
    • Urinary Tract Infection
    • Analyzers
    • Reagent Strips
    • Controls (UA)
    • See More
  • Women's Health
    • Pregnancy
    • See More
  • Cancer Screening
    • Colon Cancer Screening (FIT)
    • See More
  • Accessories
    • Urine Specimen Cups
    • Specimen Collection Accessories
    • Gloves
    • Misc
    • See More
Filters Clear All
  • FormatType

  • SpecimenType

  • SubCategory

Sort And Filter

FormatType

SpecimenType

SubCategory

Clear All
Apply Filters
Fecal Immunochemical Test Colon Cancer Screening Test Kit

Fecal Immunochemical Test (FIT) Cassette

Format: Cassette

Kit Size: 36 Tests / Kit

Fecal Immunochemical Test Colon Cancer Screening Test Mailer

Fecal Immunochemical Test (FIT) Mailer

Format: Card

Kit Size: 50 Mailers / Kit

Fecal Immunochemical Test Colon Cancer Screening Test controls

Fecal Immunochemical Test (FIT) Control Solutions

Kit Size: 1 Pair / Kit

Fecal Immunochemical Test Colon Cancer Screening Test Box and Buffer Collection Tube

Fecal Immunochemical Test (FIT) Buffer/Collection Tubes

Kit Size: 30 Tubes / Kit

Introduction to Cancer Screening

What is colorectal cancer?

Colorectal cancer is a disease in which cells in the colon or rectum grow out of control. Abnormal growths, called polyps, form in the colon or rectum. Over time, some polyps may turn into cancer. Screening tests aid in the early detection of colorectal cancer, providing information for when to seek treatment.

What are the symptoms? 

Symptoms of colorectal cancer include:

  • Change in bowl habits.
  • Blood in or on your stool (bowel movement).
  • Diarrhea, constipation, or feeling that the bowel does not empty all the way.
  • Abdominal pain, aches, or cramps that don’t go away.
  • Unknown weight loss

Source: National Center for Chronic Disease Prevention and Health Promotion; Division of Cancer Prevention and Control

What are the risk factors?

The risk of colorectal cancer increases as you get older. Risk factors include:
•    Inflammatory bowel disease
•    Family history of colorectal cancer
•    Genetic syndrome
•    Lack of physical exercise
•    Diet that is low in fruit and vegetables
•    Low fiber and high fat diet
•    Diet that is high in processed meats
•    Overweight and obesity
•    Alcohol consumption
•    Smoking or tobacco use

What can I do to reduce my risk?

The most effective way to reduce your risk of colorectal cancer is to get screened early. The American Cancer Society recommends regular colorectal cancer screening starting at age 45 for people at average risk.

What should I know about screening?

A screening test is used to detect a disease in individuals who do not show any symptoms. A screening test can detect precancerous polyps, allowing for early treatment and removal of these precancerous growths before they turn into cancer. 

What are the test options for colorectal cancer screening?

Colorectal cancer screening is crucial for early detection and treatment. There are two main groups for colorectal cancer screening tests:

  • Stool-based tests – these tests look at the stool (feces) for possible signs of colorectal cancer or polyps. There are over-the-counter tests that can be done at home, which makes it easier and convenient for regular screening. These tests are less invasive but need to be done regularly. However, if the result from these tests is positive (abnormal), a colonoscopy is needed to confirm if you have cancer. 
    • Tests include guaiac-based fecal occult blood test (gFOBT), Fecal Immunochemical Test (FIT), FIT-DNA test
  • Visual (structural) exams – these tests look at the inside of the colon and rectum for abnormal areas that may be cancer or polyps. These tests are done less often than stool-based tests but require pre-testing preparation.
    • Tests include Colonoscopy, CT colonography, sigmoidoscopy

Source: Colorectal Cancer Screening Tests | Sigmoidoscopy & Colonoscopy | American Cancer Society

How do FIT tests work?

FIT screening tests look for occult (hidden) blood in stool and help detect early signs of cancerous or pre-cancerous growths in the colon. Regular screening and treatment can help reduce risks of serious adverse effects of colorectal cancer on a person’s overall health.

About the Results and Interpreting Results

  • Positive: Two red lines appear. One red line should be in the control region I and another red line should be in the test line region (T).
  • Negative: One red line appears in the control line region I. No line appears in the test line region (T).
  • Invalid: If no lines appear or if the control line doesn’t appear, the test results are not valid. Retesting should be performed. 

Consult with your healthcare provider for follow-up and advice.

Find the best solution for your needs

Our sales representatives can help set you up for success! Contact our team today!

FAQ

Polyps are mushroom-like growths that form when cells lining the colon grow abnormally. They can become cancerous over time.

According to the WHO, colorectal cancer is the third most common cancer in the United States. 

According to the Canadian Cancer Society, colorectal cancer is the 4th most common cancer in Canada.

See your doctor for yearly screenings if you are aged 45 or older. The American Cancer Society recommends to consider starting to screen at age 45.

Guaiac-based Fecal Occult Blood Test (gFOBT) – This test detects occult (hidden) blood in the stool through a chemical reaction. It is done once a year. Stool sample is collected and then return the kit to the doctor or lab. Food and medication can affect the results of this test.

Fecal Immunochemical Test (FIT) – This test is an effective tool for colorectal cancer screening and for symptomatic assessments. This test detects occult (hidden) blood in the stool by using antibodies. It is done once a year. The test can be visually interpreted. These tests have greater clinical and analytical sensitivity.1,2 Unlike guaiac-based FOB tests (gFOBT), they have no dietary or medication restrictions prior to testing.

  1. Fraser CG et al. Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine. Clin Chem. 2012;58(6):963−5.
  2. Halloran, SP et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition. Faecal occult blood testing. Endoscopy. 2012;44:1−23.

Talk to your healthcare provider to discuss if you are eligible for a FIT test.

It is recommended that people at average risk get screened with the fecal immunochemical test (FIT) every 2 years. (Cancer Care Ontario)
The American Cancer Society recommends regular screening starting at age 45. It is recommended to take a FIT test every year. 

Which test to use depends on your preferences, medical condition, personal or family history, genetic syndrome, and available resources. Talk to your doctor about which test to use. (Centers for Disease Control and Prevention)

Lochness Medical Supplies Inc.
2775 Broadway Suite 100
Buffalo, NY 14227 USA
Tel: 1-888-506-2658
Fax: 905-248-3501

Contact Us

  • Return Policy
  • Terms of Service
  • Privacy Statement

Account

  • My Account
  • Order History

Quick Links

  • Home
  • About Us
  • Contact Us
  • Career Opportunities
  • Blog
Disclaimer: The health-related information on our website is meant for basic informational purposes only and it is not intended to serve as medical advice. While we make every effort to provide you the most accurate and up-to-date information about our products, please note that actual products may differ slightly from specifications or the pictures. Some products or services referred to in this website may not be avaliable in your territory.
© Copyright 2025. All Rights Reserved.